The drug "Cavinton forte" as an active ingredient contains vinpocetine. The medication contributes to a significant improvement in the blood circulation of the brain and the rheological properties (fluidity) of the blood.
Cavinton round tablets have a white (or almost white) color and are odorless. On one side is a CAVINTON engraving.
Cavinton medicine (tablets): instruction
The medication has a cerebroprotective effect. Means "Cavinton forte" is able to reduce the severity of cytotoxic reactions provoked by stimulating amino acids. The drug has a stimulating effect on brain metabolism, increases the absorption and absorption of oxygen and glucose by the brain.
Cavinton forte medication increases blood flow selectively. The tool is able to enhance the brain fraction of the minute volume, reduce vascular resistance, without affecting the indications of total blood circulation (minute volume, blood pressure, heart rate).
When using this medicine, there is an increase in blood supply to the affected (ischemic), but viable zone with low infusion (perfusion).
The drug is able to stimulate cerebral metabolism (metabolism) of serotonin and norepinephrine, have an antioxidant effect.
Cavinton exposure enhances the tolerance of hypoxia by brain cells. It inhibits platelet aggregation, improves brain microcirculation, reduces the increased viscosity of blood of a pathological nature, increases the ability to deform red blood cells, blocking the absorption of adenosine by them.
In neurology, the use of Cavinton forte is advisable in cases of insufficient cerebral circulation in chronic and acute form (progressive stroke, transient ischemia, conditions after a stroke, atherosclerosis of blood vessels, vascular dementia, hypertensive and post-traumatic encephalopathy and others). The drug is also indicated for neurological and mental disorders with cerebrovascular insufficiency (including dizziness, memory impairment, apraxia, headache, and motor disorders).
In ophthalmology, the drug "Cavinton forte" is prescribed for vascular ocular pathologies (angiospasm of the retina and choroid, atherosclerosis, secondary glaucoma, and others).
The medication is used in the treatment of ENT diseases (with a decrease in hearing of age, toxic or vascular origin (origin)), Meniere's disease, tinnitus, as well as vasovegetative manifestations of menopausal syndrome.
Contraindications to the appointment of the drug "Cavinton forte" are lactation and pregnancy, heart failure in severe forms, as well as hypersensitivity to vinpocetine or auxiliary components.
The dosage and duration of the therapeutic course is prescribed individually by the doctor. As a rule, it is enough to take a tablet three times a day. Drinking medication is recommended after eating. The therapeutic course can last from one to eight months, usually an average of three to four months. With the withdrawal of the drug, the dosage decreases gradually over a period of two to three days.
The use of the drug can provoke an increase in the manifestations of existing arrhythmia. Dry mouth, weakness, heartburn, sleep disturbance, skin rash, nausea, headache, urticaria, and flushing of the skin sometimes occur.
Cavinton does not have hepato- and nephrotoxic effects, in connection with this, when it is prescribed to patients with hepatic or renal pathologies, dosage adjustment is not required.
The drug is not recommended for use in children under 18 years of age due to insufficient knowledge of the effects of its components on the children's body.